Literature DB >> 22342516

[Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis].

R Bustos B1, C Carrasco A, C Toledo R.   

Abstract

The use of extracorporeal techniques for the treatment of paediatric diseases has expanded dramatically in the past decade. Plasmapheresis, a technique for exchanging plasma components with albumin or plasma, has been used in some rheumatologic conditions. We report the clinical course of a 7 years old boy with clinical and biological features of macrophage activation syndrome and multiorgan failure, at the time of presentation of severe juvenile dermatomyositis, and non responsive to corticosteroids, cyclosporine and immunoglobulin. After 4 days in the paediatric intensive care unit, plasmapheresis was used as rescue therapy. Repeated therapeutic plasmapheresis was effective for improving the multiorgan failure and laboratory abnormalities. The patient was discharged on the 21st hospital day with good functional condition. Plasmapheresis should be considered as rescue treatment in patients with life threatening macrophage activation syndrome and systemic onset of juvenile dermatomyositis.
Copyright © 2011 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22342516     DOI: 10.1016/j.anpedi.2011.12.011

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  3 in total

Review 1.  Macrophage activation syndrome in juvenile dermatomyositis: a systematic review.

Authors:  Dimitri Poddighe; Kaisar Dauyey
Journal:  Rheumatol Int       Date:  2019-09-16       Impact factor: 2.631

Review 2.  [What are the indications for rescue procedures? : Systemic rheumatic diseases in the intensive care unit].

Authors:  B Hellmich; C Löffler
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

3.  Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.

Authors:  Hiroyuki Wakiguchi; Shunji Hasegawa; Reiji Hirano; Hidenobu Kaneyasu; Midori Wakabayashi-Takahara; Shouichi Ohga
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-18       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.